Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22023,195,1.34 [0.95-1.90],0.0937786332683487
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23244,251,0.96 [0.71-1.30],0.8046421669148194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22968,1772,0.88 [0.78-0.98],0.0243588023563226
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Candidiasis,23252,552,0.72 [0.59-0.88],0.0011328497324772
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22489,4262,0.86 [0.80-0.92],3.691622721505855e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22430,4336,0.90 [0.84-0.97],0.0061903875802467
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22957,1436,0.92 [0.81-1.04],0.194684479628984
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23155,131,1.20 [0.79-1.83],0.3867565968971581
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20415,1313,0.96 [0.84-1.10],0.545487895729021
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19693,1597,0.89 [0.79-1.00],0.0593327836079917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19189,343,0.73 [0.57-0.95],0.0173243017946696
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15129,2768,0.85 [0.78-0.94],0.000754609437653
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19129,501,0.67 [0.54-0.83],0.0002326142989187
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23228,1707,0.93 [0.83-1.05],0.2245713166253838
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,23348,648,0.72 [0.60-0.87],0.0005352089163496
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22451,1255,0.83 [0.73-0.96],0.0088218465889331
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23276,1448,0.99 [0.88-1.13],0.9230105617579024
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21772,251,0.96 [0.71-1.30],0.7866777434447383
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23408,67,0.84 [0.47-1.50],0.5519963133637518
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23094,1266,0.97 [0.85-1.11],0.6605335150962648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23104,80,1.06 [0.62-1.81],0.8435786910929062
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23341,141,0.74 [0.50-1.10],0.1362517462071714
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23319,119,0.67 [0.44-1.03],0.0690902803772221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21703,507,1.30 [1.05-1.62],0.0162421526191951
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21507,311,0.72 [0.55-0.94],0.0155885214216365
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21660,139,1.03 [0.69-1.55],0.8684379084100822
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23393,52,1.45 [0.75-2.82],0.2736140743425419
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23340,174,0.63 [0.44-0.90],0.0111312413979108
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral warts,23221,55,0.56 [0.30-1.05],0.0694356955166655
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23245,79,0.91 [0.53-1.57],0.737433653771919
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,23112,265,1.39 [1.04-1.87],0.028085235574872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23324,38,1.65 [0.76-3.58],0.2025607221964614
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23307,44,1.67 [0.82-3.41],0.1593630161871105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11157,86,1.38 [0.82-2.33],0.2205462845004699
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22936,1685,0.94 [0.83-1.05],0.2696562168269859
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of meninges,23392,64,1.13 [0.62-2.06],0.6846296255200177
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23312,80,0.99 [0.58-1.69],0.9657002240634048
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23380,119,0.94 [0.61-1.46],0.7914601404630589
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of ovary,12181,80,0.80 [0.47-1.36],0.4114247408479093
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23368,444,1.01 [0.80-1.27],0.9400276632142868
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Caecum,23373,384,0.92 [0.72-1.18],0.5331347358718288
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23257,88,1.03 [0.62-1.72],0.9092138167681054
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Descending colon,23365,254,0.77 [0.57-1.04],0.0869954866532885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,23323,413,1.13 [0.89-1.43],0.3052580800636179
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23251,678,0.92 [0.76-1.10],0.3553311038611162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23351,544,0.87 [0.71-1.07],0.1955351126640538
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Carcinoma in situ of breast,9160,50,1.83 [0.94-3.58],0.0759326421774585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9204,68,1.05 [0.59-1.88],0.8690745062646381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16703,73,1.20 [0.68-2.13],0.5265961162924561
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16731,101,1.04 [0.64-1.69],0.8684940505990262
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23350,127,1.03 [0.67-1.59],0.875094712865821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",23351,124,1.01 [0.65-1.55],0.9796802266052572
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,11910,170,1.35 [0.93-1.95],0.1156153961440479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lung cancer and mesothelioma,14817,483,0.59 [0.48-0.73],7.041109442178095e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lymphoid leukaemia,16704,74,1.28 [0.72-2.25],0.3999229663610074
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16859,229,1.12 [0.82-1.55],0.4771707850123134
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16954,324,0.78 [0.60-1.02],0.0705326502446088
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9284,105,1.48 [0.93-2.36],0.0974005864573225
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16739,109,1.04 [0.65-1.64],0.8820731012259682
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16780,150,0.87 [0.59-1.28],0.4793995061773195
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16754,124,0.63 [0.41-0.95],0.0285782126386522
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9266,87,0.97 [0.58-1.62],0.9014544862935248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16758,128,0.69 [0.46-1.05],0.0818369899649305
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8443,992,1.14 [0.98-1.33],0.0927752809994294
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16769,139,0.82 [0.54-1.23],0.3323600176254886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16723,93,0.65 [0.40-1.06],0.087355386621114
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16776,146,0.95 [0.63-1.41],0.7835416058730906
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,23260,186,1.16 [0.81-1.65],0.4151344584103937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of trunk,23379,78,0.95 [0.55-1.64],0.8564666011055019
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanoma in situ,16683,112,0.84 [0.53-1.32],0.4383426414062115
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16753,123,1.10 [0.71-1.71],0.6591630446607208
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16831,201,1.41 [1.00-1.98],0.0505815171965728
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16960,330,0.68 [0.53-0.88],0.0027980685241274
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16759,129,1.56 [1.02-2.38],0.042455263460529
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,23232,168,1.14 [0.79-1.66],0.4783646818829692
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18139,1509,1.05 [0.93-1.20],0.4042890576264181
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18225,1595,1.06 [0.94-1.20],0.3358004277886239
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23100,398,1.27 [1.00-1.61],0.0533610348912566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21057,167,0.69 [0.48-1.00],0.0488347798889935
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22773,71,0.85 [0.48-1.50],0.567779497665049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22628,3538,0.89 [0.82-0.97],0.0064697390114071
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21666,73,0.99 [0.57-1.73],0.9730996831501584
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22928,62,1.62 [0.88-2.98],0.1206144247088199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22883,1993,0.88 [0.79-0.98],0.0199382541414867
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22881,1991,0.88 [0.79-0.98],0.0217904306967832
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21006,116,0.80 [0.51-1.25],0.3298686625972598
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23039,1446,0.84 [0.74-0.95],0.0071687027586188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22980,114,0.63 [0.41-0.98],0.0397906656026796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22775,73,1.03 [0.59-1.79],0.9237108658289516
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22778,76,0.85 [0.49-1.48],0.5753486116233214
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23223,357,1.20 [0.93-1.55],0.1577053855080199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23278,39,2.34 [1.09-5.00],0.0283642930732635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23161,295,1.30 [0.98-1.73],0.0638413374299012
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21732,139,0.82 [0.55-1.22],0.3246136537982957
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15662,419,0.85 [0.67-1.07],0.1699860544736117
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21886,105,1.04 [0.65-1.65],0.8832839749492742
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21895,114,0.79 [0.52-1.20],0.2770234240549885
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15315,72,0.36 [0.22-0.61],0.0001154502784312
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21737,65,0.92 [0.51-1.65],0.7697082017407503
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20945,324,0.93 [0.71-1.21],0.583320524725109
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22606,970,0.84 [0.72-0.98],0.0299325768804686
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22121,485,0.93 [0.74-1.15],0.4935353044426185
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21855,219,0.71 [0.51-0.97],0.0342987471137163
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23117,1445,0.97 [0.85-1.10],0.6115588402610139
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19690,1400,0.93 [0.82-1.06],0.2626888160602226
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15336,93,0.72 [0.44-1.17],0.1870825287683687
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21085,101,0.73 [0.46-1.17],0.1888504757742658
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15613,370,0.64 [0.50-0.82],0.0004322402673734
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15298,55,1.56 [0.80-3.03],0.1912273151544046
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19894,4651,0.80 [0.75-0.86],8.99650298180289e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15510,267,0.60 [0.45-0.80],0.0004427877934441
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15958,715,0.77 [0.64-0.92],0.0035787517652306
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23346,375,0.81 [0.64-1.04],0.0990515277304971
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23134,163,1.48 [1.02-2.16],0.0393869067539689
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15399,156,0.87 [0.59-1.29],0.4985203725449544
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15325,82,0.67 [0.40-1.14],0.1379391958190783
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22761,1777,1.06 [0.95-1.19],0.2840281787631988
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15629,386,0.89 [0.70-1.14],0.3534094155280007
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15675,432,1.07 [0.85-1.36],0.5584712080241823
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16116,873,0.75 [0.64-0.88],0.0004936748419337
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15421,178,0.66 [0.46-0.95],0.0240257539346254
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23124,153,1.61 [1.10-2.37],0.0151314470649708
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16148,905,0.55 [0.47-0.64],3.4648733216273794e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15906,663,0.70 [0.58-0.84],0.0001061216912438
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20702,81,0.62 [0.37-1.05],0.075958695153267
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21744,6501,0.81 [0.76-0.86],3.639880761449291e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21045,61,0.98 [0.53-1.81],0.9579759274724604
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21033,49,0.75 [0.38-1.48],0.4080616838138875
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23220,1931,0.86 [0.77-0.95],0.0053450502537206
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23218,1929,0.85 [0.76-0.95],0.0037711914325682
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21050,66,1.01 [0.56-1.82],0.9750151833538117
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23046,1148,0.86 [0.75-0.99],0.0362807948635721
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17501,2258,0.71 [0.64-0.79],2.918868213176893e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23392,317,0.87 [0.67-1.14],0.3059803665348526
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21768,132,0.79 [0.52-1.19],0.2601201967367917
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22018,120,1.03 [0.66-1.59],0.9082040895649616
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22065,167,1.12 [0.77-1.62],0.5663089062429957
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15445,202,0.95 [0.67-1.33],0.7499741045406558
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20580,187,0.85 [0.59-1.21],0.3562512457343948
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2506,101,1.61 [1.02-2.56],0.0428350242637801
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2674,311,0.94 [0.72-1.24],0.6763375210221222
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20478,85,0.92 [0.53-1.59],0.7742651819191992
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2478,76,2.10 [1.25-3.54],0.0052736161394705
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22551,2158,0.66 [0.59-0.73],5.927362612287055e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22274,638,0.98 [0.81-1.19],0.8745310096995704
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21078,457,0.95 [0.76-1.18],0.6343645843201943
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16369,1126,0.76 [0.66-0.88],0.0002135383042273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23272,305,1.42 [1.08-1.88],0.0121271745430923
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21890,271,0.67 [0.50-0.89],0.0058424914112417
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,20217,1587,0.80 [0.71-0.90],0.0002802510071837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21997,378,0.84 [0.66-1.07],0.1571550961618407
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21708,89,0.84 [0.51-1.39],0.4976639066175656
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21915,296,0.86 [0.65-1.13],0.2804015306632145
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11850,2875,0.87 [0.79-0.95],0.003104827956922
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,AV-block,17784,687,0.86 [0.71-1.03],0.0962902389530275
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23322,583,1.11 [0.91-1.35],0.31541107823966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiac arrest,9240,265,0.96 [0.71-1.29],0.7683783020015189
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17303,206,0.95 [0.68-1.33],0.7665275637775821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17208,111,0.95 [0.60-1.49],0.8131868634401977
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23402,83,0.87 [0.51-1.48],0.6095764116409038
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,18671,1574,0.91 [0.80-1.02],0.1100305835652032
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21391,2786,0.83 [0.75-0.90],3.7750127357970886e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18789,9008,0.82 [0.78-0.87],1.2853427309965897e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21823,335,1.33 [1.02-1.73],0.0346129848104486
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Endocarditis,17201,104,0.55 [0.35-0.87],0.0106222812598944
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23114,1689,0.99 [0.89-1.12],0.9300787114975712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,20034,8010,0.81 [0.77-0.85],1.4250727748011555e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20054,8030,0.81 [0.77-0.86],4.257482354962503e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23232,95,1.18 [0.72-1.94],0.5139450672843855
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12288,264,0.65 [0.48-0.87],0.0036398761243414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12237,213,0.60 [0.43-0.82],0.0017553589605054
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,23221,1660,0.86 [0.76-0.97],0.0109311574985721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22097,149,0.77 [0.52-1.14],0.1932120373424777
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21565,2935,0.84 [0.77-0.91],7.285354384272029e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22884,809,0.86 [0.73-1.02],0.0805295140935113
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17625,528,1.05 [0.85-1.30],0.6279797327005885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22708,1072,0.83 [0.72-0.97],0.0148100093802303
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19553,923,0.83 [0.71-0.97],0.0168242692414827
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23277,192,0.92 [0.65-1.30],0.6373535202104285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23364,410,0.74 [0.58-0.93],0.0110376370083596
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Oesophageal varices,21554,66,1.06 [0.59-1.92],0.8413588581032905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other aneurysm,21726,107,0.65 [0.42-1.03],0.0672651612306733
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,17700,603,1.00 [0.82-1.21],0.9858551230907544
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21756,137,0.83 [0.56-1.24],0.3714811350477335
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21952,333,0.65 [0.50-0.84],0.0009707886716849
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17325,228,0.95 [0.69-1.31],0.7703251342257016
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other disorders of veins,21609,121,1.09 [0.71-1.68],0.6837893606099238
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21536,48,0.61 [0.32-1.20],0.1517870173695574
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21324,92,0.59 [0.36-0.96],0.0348842461095564
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21670,182,1.01 [0.72-1.44],0.9352543606421492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18578,1481,0.96 [0.85-1.09],0.5103935517702811
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21623,62,1.06 [0.58-1.95],0.849379618927813
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22358,739,1.03 [0.86-1.22],0.750451364010516
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22624,534,0.82 [0.67-1.01],0.0623614282610954
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22223,991,0.79 [0.68-0.91],0.0017182132999338
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9399,424,0.88 [0.70-1.12],0.3112953532884112
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22185,602,1.00 [0.83-1.22],0.9629112674666684
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21913,425,1.30 [1.03-1.64],0.0293705654946174
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22702,612,0.92 [0.76-1.12],0.4132054291634914
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23306,980,0.99 [0.85-1.16],0.938803164727761
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17617,520,0.91 [0.74-1.13],0.390602169449169
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22617,527,0.83 [0.68-1.02],0.0800006068054049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21501,269,1.01 [0.75-1.35],0.9700624531518895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22868,920,0.84 [0.72-0.99],0.0322548126627055
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22853,960,0.87 [0.74-1.01],0.0663238393474217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22064,63,1.02 [0.56-1.86],0.941365856089728
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21725,106,1.31 [0.82-2.08],0.2598340024708207
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22402,327,0.70 [0.54-0.91],0.0069616250062472
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21974,338,0.79 [0.61-1.03],0.0782966196804482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,22009,521,1.31 [1.06-1.61],0.0132302936664371
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21640,125,0.75 [0.49-1.14],0.178015377622403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23129,959,1.05 [0.90-1.23],0.5257328974254779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23324,335,0.95 [0.73-1.22],0.6689939976376549
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19991,1400,0.86 [0.76-0.98],0.0234946004216311
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,22865,4274,0.87 [0.81-0.94],0.0002583239781433
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23295,396,1.02 [0.80-1.29],0.8961219512791428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20064,1473,0.94 [0.83-1.07],0.3508387366064679
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18676,85,0.96 [0.57-1.61],0.8762841074587573
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,22890,1192,0.76 [0.67-0.86],1.769971167890843e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20057,1466,0.82 [0.73-0.93],0.0019456681073858
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Vascular dementia,22497,235,0.70 [0.51-0.95],0.0240481967220218
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Alzheimer disease,23404,596,0.92 [0.75-1.12],0.3842919568627965
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14323,111,0.96 [0.61-1.53],0.865256007286078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Bell's palsy,21527,88,0.70 [0.42-1.15],0.1559175321847744
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21940,501,0.85 [0.69-1.05],0.1408042563900894
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral cysts,22950,251,0.88 [0.65-1.19],0.419998638590258
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23330,414,0.90 [0.72-1.14],0.3981620589159178
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22543,75,0.79 [0.45-1.37],0.3954373009557961
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23386,68,0.72 [0.41-1.29],0.2697634031729431
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22786,87,0.94 [0.56-1.58],0.8173066709346088
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,21870,309,0.79 [0.60-1.04],0.0923116996194229
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22933,1372,0.86 [0.75-0.98],0.0202154148628886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23350,937,0.86 [0.74-1.01],0.0651118291927502
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22739,3494,0.90 [0.83-0.97],0.0079220439683112
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Generalized epilepsy,23018,54,0.61 [0.33-1.16],0.1323084764677616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,23255,339,0.94 [0.73-1.22],0.6504790527627049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hydrocephalus,22774,75,0.54 [0.32-0.91],0.0203573514662356
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23391,75,0.58 [0.34-0.99],0.0472620285289057
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21507,68,1.18 [0.66-2.11],0.5853999606706815
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21513,74,0.87 [0.50-1.52],0.6302475628447587
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Memory loss,22240,143,1.12 [0.75-1.68],0.5899274296979076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,21847,286,0.85 [0.64-1.13],0.2669634143153406
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23356,262,0.82 [0.61-1.10],0.1791405575280467
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Motor neuron disease,14412,176,0.66 [0.46-0.95],0.0272913854255925
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23269,61,0.59 [0.33-1.06],0.0751675311925984
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22686,1247,0.78 [0.68-0.89],0.000262754343193
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,21893,4414,0.87 [0.81-0.93],0.0001166349622411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22796,328,0.81 [0.62-1.05],0.1174182107271258
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21871,432,0.61 [0.49-0.77],2.1400885025433942e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23326,357,1.03 [0.80-1.33],0.8171898174895673
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17495,986,0.83 [0.71-0.97],0.0190745726137555
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22787,88,0.92 [0.55-1.52],0.7393303646158826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22861,162,0.62 [0.43-0.89],0.0101699185392798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22650,237,0.82 [0.60-1.11],0.1992113190814141
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21538,99,0.65 [0.40-1.03],0.0692335696258059
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other headache syndromes,21614,53,1.01 [0.52-1.96],0.9713157074017814
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,23288,589,0.78 [0.64-0.95],0.0124104889417699
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,22084,523,0.83 [0.67-1.02],0.0804589194214382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Parkinson's disease,23371,696,0.91 [0.76-1.10],0.3264813274846678
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22744,45,0.69 [0.35-1.40],0.3060653247852784
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Restless leg syndrome,23405,109,0.81 [0.51-1.27],0.3531576830826374
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,23170,445,0.90 [0.72-1.13],0.370595391396565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23031,62,1.63 [0.88-3.03],0.1226556410697315
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23393,205,0.74 [0.53-1.02],0.0693775501210447
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21510,71,0.81 [0.46-1.43],0.4737738275187829
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23404,602,0.92 [0.76-1.12],0.3983431007999215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22434,229,0.72 [0.53-0.99],0.043586404935574
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22746,157,0.85 [0.58-1.25],0.4085272589354729
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22940,572,0.93 [0.76-1.14],0.4811070699254652
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23146,269,0.64 [0.48-0.86],0.0027260815124253
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22153,69,1.01 [0.56-1.82],0.9611249791233178
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22123,39,1.16 [0.53-2.52],0.7042959931786066
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23280,73,0.96 [0.55-1.69],0.8991418754740146
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23085,229,0.82 [0.60-1.12],0.2155622494826218
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2482,77,2.02 [1.21-3.39],0.0071954810176768
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3060,115,1.86 [1.22-2.83],0.0039452099450835
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22700,111,0.72 [0.46-1.12],0.1435497364835282
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23101,1444,0.90 [0.79-1.02],0.0941451698683693
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22981,897,0.91 [0.77-1.06],0.2286679865518744
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22393,309,0.83 [0.64-1.09],0.1911436020556865
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23329,961,0.90 [0.77-1.05],0.1720222888771503
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23398,83,1.11 [0.65-1.88],0.7073516089126973
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23255,887,0.87 [0.74-1.03],0.1016636018607377
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23362,506,0.80 [0.65-0.99],0.0386979060948379
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23283,229,0.92 [0.67-1.26],0.6153917387875804
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22187,103,0.80 [0.50-1.29],0.3702895430332371
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22187,103,0.72 [0.45-1.16],0.1759404564167204
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22162,78,1.31 [0.76-2.27],0.3306551305493058
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23270,1030,0.95 [0.81-1.10],0.4679664890805887
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22509,269,0.95 [0.71-1.27],0.7075296934237021
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22441,73,0.77 [0.44-1.34],0.3546762744761067
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22980,124,0.97 [0.63-1.50],0.900750569839108
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23252,396,0.76 [0.60-0.96],0.0226275540327577
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22590,222,0.81 [0.59-1.11],0.191979231449247
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23199,145,0.70 [0.47-1.03],0.071941212322808
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22929,689,0.89 [0.74-1.06],0.192056570920637
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22751,162,0.85 [0.58-1.24],0.3905491884444894
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20916,3284,0.87 [0.80-0.94],0.0008056384477218
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23207,351,0.79 [0.61-1.01],0.0621983188316852
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23390,190,0.86 [0.60-1.21],0.3762843664049502
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22634,550,0.95 [0.77-1.17],0.6280497277423103
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22946,90,0.84 [0.51-1.40],0.511454863770693
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23389,74,1.16 [0.66-2.03],0.6047543276886431
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22214,130,0.84 [0.55-1.29],0.4292240661975591
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22263,179,1.17 [0.82-1.69],0.3823481627300977
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21821,164,1.18 [0.81-1.73],0.3831662525077561
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22432,64,1.19 [0.65-2.18],0.5697347123268856
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21732,75,0.68 [0.39-1.18],0.1723260285048242
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22357,117,0.76 [0.49-1.18],0.2288230261477855
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22539,299,0.84 [0.64-1.11],0.2131498534684821
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22246,162,0.81 [0.56-1.18],0.2793850555338979
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21752,95,0.66 [0.41-1.08],0.0961325556840193
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21791,134,1.03 [0.68-1.56],0.8974056834962142
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20404,2772,0.84 [0.77-0.92],0.0001731755920031
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22179,95,1.22 [0.74-2.01],0.4250285125288277
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23104,515,0.81 [0.65-0.99],0.0431137839790135
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22669,80,1.14 [0.67-1.94],0.6312183005559677
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22801,212,0.93 [0.67-1.29],0.6730619582478853
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23180,111,1.06 [0.67-1.68],0.8063914134702075
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23358,141,0.78 [0.53-1.17],0.2337641518678981
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23266,120,1.04 [0.67-1.61],0.8635379105091452
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23133,64,0.76 [0.42-1.37],0.3638348436149936
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23139,70,1.09 [0.61-1.93],0.7799983974892493
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23298,1263,0.92 [0.80-1.05],0.2030145747950524
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22991,956,0.98 [0.84-1.15],0.8210962471312391
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22191,156,0.85 [0.58-1.25],0.4205717753848604
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22126,91,0.64 [0.39-1.05],0.078844390192245
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute pharyngitis,23210,67,0.95 [0.53-1.72],0.8771902463641562
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23332,189,1.14 [0.80-1.62],0.4555858298470639
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23207,64,1.28 [0.70-2.34],0.4244116651516886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza,20695,159,0.86 [0.58-1.25],0.4252833685184942
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20692,156,0.87 [0.59-1.27],0.4649032738806538
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14437,103,0.92 [0.57-1.49],0.7405387806367592
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic rhinitis,23295,240,0.82 [0.60-1.11],0.2035071730352279
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15672,1735,0.81 [0.72-0.91],0.0002770829179945
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16046,1712,0.80 [0.71-0.90],0.0002205684613136
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22883,180,0.72 [0.51-1.03],0.0718880317997205
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20641,105,0.62 [0.39-0.98],0.0416880969274961
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bronchiectasis,19619,517,0.73 [0.59-0.90],0.0026719399124493
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19175,73,0.53 [0.31-0.91],0.0220175626093691
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22262,3160,0.79 [0.72-0.86],2.5021722858637293e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22171,73,1.13 [0.64-1.98],0.6782534136209708
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,22236,138,0.80 [0.54-1.20],0.2890357045510285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23110,1647,0.75 [0.67-0.84],1.035383068910145e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,22179,81,0.95 [0.56-1.62],0.8449993445901746
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21236,6176,0.86 [0.81-0.92],2.342021768317755e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22436,338,0.76 [0.59-0.98],0.0346533901540417
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,21573,110,0.64 [0.41-0.99],0.0441756112061844
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Emphysema,19543,441,0.61 [0.49-0.76],6.958426013795453e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22087,459,0.48 [0.39-0.60],3.430366416494973e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23145,2609,0.79 [0.72-0.87],5.781913909655988e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,22130,502,0.52 [0.42-0.64],9.480978787051235e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Later onset COPD,22876,1537,0.75 [0.67-0.85],3.588636989492564e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23388,501,0.80 [0.65-0.99],0.0448291499847052
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,22198,100,1.10 [0.68-1.79],0.6900749345421542
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23119,1313,0.90 [0.79-1.03],0.1192965405283013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,23110,2708,0.85 [0.78-0.94],0.0006753589906955
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22857,759,0.87 [0.73-1.04],0.1285668412450668
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other pleural conditions,20468,66,0.89 [0.49-1.61],0.7055727054310243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23284,599,0.60 [0.50-0.73],1.8846816224560368e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23274,1726,0.82 [0.73-0.91],0.0004308786094999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,21784,1382,0.91 [0.80-1.03],0.1375076957847283
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural plaque,20656,254,0.85 [0.63-1.15],0.2908546576304276
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22854,2318,0.78 [0.71-0.87],1.474005373679748e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23277,390,0.78 [0.61-0.99],0.0444789137621308
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumothorax,20573,171,0.71 [0.50-1.02],0.0607720934965966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pollen allergy,23393,204,0.81 [0.58-1.14],0.2257651380759525
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pulmonary oedema,22778,93,0.77 [0.47-1.26],0.2939536042556931
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14405,71,0.58 [0.33-0.99],0.0475655982488077
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23096,1290,0.89 [0.78-1.02],0.0898100740770461
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22340,242,0.82 [0.60-1.11],0.2032716861888954
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Viral pneumonia,20841,305,0.79 [0.60-1.04],0.0952359656288565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22891,244,0.73 [0.54-1.00],0.0465800280361805
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7465,120,0.50 [0.33-0.77],0.0014822224940679
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14825,62,0.95 [0.51-1.75],0.862799159106232
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,23288,131,1.50 [0.98-2.28],0.0589811986626203
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute gastritis,16253,104,0.96 [0.60-1.54],0.8547551375139353
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,21335,198,1.11 [0.78-1.56],0.5639807238753026
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute peritonitis,22906,112,1.20 [0.76-1.88],0.4326129925980767
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22410,64,1.22 [0.68-2.20],0.5098341302168669
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Barrett oesophagus,16664,515,0.80 [0.65-0.99],0.0384724658651954
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21282,145,0.80 [0.54-1.19],0.2779858476798071
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22981,145,0.80 [0.54-1.20],0.2775210072252705
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,21361,224,0.96 [0.70-1.32],0.8050199963007165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,22202,1065,0.98 [0.84-1.13],0.7707693140884635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,16502,353,1.10 [0.85-1.42],0.4823232021360399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21193,56,0.42 [0.23-0.76],0.0042267165916862
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23264,127,0.88 [0.58-1.34],0.5503709079751178
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,21641,129,0.91 [0.60-1.39],0.6687242403582228
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Collagenous colitis,21639,104,0.77 [0.48-1.22],0.2607044585065979
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23287,158,0.79 [0.54-1.16],0.2287419847566478
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,23116,2157,0.83 [0.75-0.92],0.000327549868583
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,21624,89,0.52 [0.32-0.84],0.0081116111564794
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23051,68,0.69 [0.39-1.22],0.2047955894511693
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21616,81,0.61 [0.36-1.02],0.057634486489548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,22777,190,0.66 [0.47-0.92],0.0146216952170934
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20212,2584,0.85 [0.77-0.93],0.0007256762057173
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,23319,162,1.40 [0.96-2.04],0.0822800147352042
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,23281,935,0.95 [0.81-1.11],0.4984422641766263
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20806,4657,0.90 [0.84-0.97],0.0038606615551937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23065,478,0.86 [0.69-1.07],0.1791512742348473
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23314,520,1.24 [1.00-1.53],0.0492054947674301
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22682,95,1.14 [0.70-1.87],0.5976356210125979
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22552,60,0.89 [0.48-1.63],0.6977117875307515
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23064,1552,0.92 [0.81-1.04],0.1746279420456315
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of tongue,22570,98,0.59 [0.37-0.94],0.0251385534973098
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22673,1536,0.97 [0.86-1.10],0.6471019982886407
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18580,3817,0.83 [0.77-0.90],3.5256334000302613e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,16401,252,0.86 [0.64-1.17],0.3339796054771981
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23308,204,0.80 [0.57-1.11],0.1781957198861744
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23366,27,0.49 [0.21-1.16],0.1062562887393156
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22495,149,0.86 [0.58-1.27],0.4394564200748477
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14871,108,0.85 [0.54-1.35],0.4956725160500613
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,16721,572,0.82 [0.67-1.01],0.0588638543712555
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,16579,430,0.78 [0.62-0.98],0.0357147626805297
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18856,2707,0.87 [0.79-0.95],0.0023059689969729
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16807,658,0.79 [0.65-0.95],0.0116028339002229
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16891,8314,0.92 [0.88-0.97],0.0035238970078964
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,22801,1289,0.92 [0.81-1.06],0.2450301920200617
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22633,46,1.01 [0.50-2.06],0.9720347144405728
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15767,1198,0.87 [0.76-1.00],0.0504225596146403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22416,70,1.14 [0.64-2.02],0.6563357231751508
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,21314,3686,0.91 [0.84-0.98],0.0192091818572286
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,23370,25,0.46 [0.20-1.10],0.0827814713588133
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impaction of intestines,14842,79,0.96 [0.56-1.65],0.8799170848450081
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,18743,1115,1.00 [0.87-1.16],0.9634736989487304
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17754,126,1.25 [0.81-1.94],0.3124774136164379
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14882,119,0.62 [0.40-0.95],0.0283510067237637
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21660,148,0.92 [0.62-1.36],0.6786492471489645
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15282,519,0.80 [0.65-0.99],0.0374483809710743
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23373,343,0.71 [0.55-0.92],0.0090478889034987
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22327,792,0.93 [0.78-1.10],0.4087713740876889
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22639,1104,0.93 [0.80-1.07],0.3108502087880095
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16371,222,0.79 [0.57-1.09],0.1436944413394888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,16859,710,0.85 [0.71-1.02],0.0755951656550364
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23349,136,1.07 [0.71-1.61],0.7362027255510117
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17716,88,0.70 [0.42-1.17],0.1708195114960883
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16158,1395,0.91 [0.80-1.04],0.1705339639459656
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21500,363,0.70 [0.55-0.90],0.0045988112787861
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21287,150,1.05 [0.71-1.56],0.7966590722657927
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,16720,1957,0.84 [0.76-0.94],0.0022582826029051
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,21052,6289,0.87 [0.82-0.93],1.485728094193187e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22530,209,0.92 [0.66-1.28],0.610321964474116
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,23119,773,0.93 [0.78-1.10],0.4019802023504997
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16928,779,0.78 [0.66-0.93],0.0048677670424086
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21352,215,1.05 [0.76-1.46],0.7562402347712254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23236,442,1.21 [0.96-1.52],0.106355263280409
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17258,1109,0.79 [0.68-0.91],0.0014254022850937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22818,1306,0.92 [0.81-1.05],0.2426918174140065
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22768,181,0.92 [0.65-1.31],0.6477860094013841
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16966,2203,0.81 [0.73-0.89],3.4387863379567744e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18341,2192,0.90 [0.81-0.99],0.035191219501566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22460,114,0.67 [0.43-1.04],0.0736509994772542
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22507,972,0.92 [0.79-1.08],0.2995864338986267
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15216,453,0.83 [0.66-1.04],0.1113942480007317
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23362,31,0.42 [0.20-0.89],0.0245404276340879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15390,627,0.79 [0.65-0.95],0.0139226864226872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21672,160,0.72 [0.49-1.04],0.0787841306125316
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23393,54,1.21 [0.63-2.32],0.5728240024860285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22580,104,1.39 [0.87-2.23],0.1681872091653279
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Toxic colitis,21617,82,0.87 [0.51-1.49],0.6180142551636048
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16493,344,0.69 [0.53-0.89],0.0044882112882314
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,21706,171,1.00 [0.69-1.45],0.9965145695790985
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21671,136,0.97 [0.64-1.47],0.8814273879074144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,17886,258,1.10 [0.82-1.49],0.5228059213026188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,15012,249,0.74 [0.55-1.01],0.053921786603885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,17920,292,0.97 [0.73-1.28],0.8173552938684694
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Volvulus,14857,94,0.81 [0.49-1.32],0.3951196434929334
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23296,431,0.81 [0.64-1.02],0.0759027749854992
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23036,67,2.29 [1.29-4.08],0.004803758783234
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20811,170,1.02 [0.71-1.48],0.9022942310144424
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22764,839,1.02 [0.87-1.21],0.7762079869569302
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22071,146,0.89 [0.60-1.32],0.5577944423235832
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21282,641,0.81 [0.67-0.98],0.0319955721524616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23055,319,0.91 [0.69-1.18],0.4666117903295016
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23302,566,0.85 [0.70-1.04],0.1124479137430406
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22785,49,0.57 [0.29-1.10],0.0922158316065297
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21781,3777,0.95 [0.87-1.02],0.1588351124003626
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22967,445,1.09 [0.86-1.36],0.4806076993421817
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22831,309,0.95 [0.73-1.25],0.7291423256250644
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23016,1091,0.96 [0.83-1.11],0.5610360546744442
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23384,61,1.03 [0.56-1.90],0.9287836756901896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20698,57,0.44 [0.25-0.78],0.0045599380313825
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22586,64,1.84 [1.02-3.35],0.0444721599441681
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23041,305,0.96 [0.73-1.27],0.7886716770883562
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21252,611,0.91 [0.75-1.11],0.3552411881439511
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20731,90,1.41 [0.85-2.33],0.1835631445250712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23316,97,0.94 [0.58-1.53],0.8013083772760127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22164,239,1.03 [0.75-1.40],0.8723207051712966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23197,228,0.85 [0.62-1.16],0.2984898831793798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22833,97,1.12 [0.69-1.83],0.6438453400535715
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20722,81,1.20 [0.70-2.04],0.5132575525802252
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22779,2138,0.93 [0.84-1.03],0.1629926709153028
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21298,657,0.92 [0.76-1.11],0.3918918595670279
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20735,94,1.44 [0.88-2.36],0.1466878791964379
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23311,342,1.00 [0.77-1.29],0.9771583275187122
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22811,75,0.57 [0.33-0.96],0.036229583456511
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23249,280,1.00 [0.75-1.33],0.9933798480216026
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23329,464,0.80 [0.64-1.00],0.0477695263252913
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20768,127,1.18 [0.77-1.81],0.4544543709545473
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20984,343,0.79 [0.61-1.02],0.0655859303969395
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23317,452,0.80 [0.64-1.00],0.0498204880353208
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20983,342,1.09 [0.84-1.42],0.4951437523946931
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23377,158,0.88 [0.60-1.28],0.4968570286741485
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19503,82,1.23 [0.72-2.09],0.4437354945581864
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20620,6520,0.91 [0.86-0.97],0.0025687954543443
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19196,5096,0.89 [0.83-0.95],0.0005590022572732
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19475,54,1.34 [0.70-2.58],0.3822843906107539
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19414,149,0.80 [0.54-1.18],0.261586216315074
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19459,194,1.12 [0.79-1.58],0.5245530317168008
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23139,65,1.46 [0.81-2.65],0.2088799657336204
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19417,152,0.77 [0.53-1.14],0.1931744767040627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15604,1504,0.94 [0.83-1.07],0.3295498541453848
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23191,251,1.26 [0.93-1.71],0.1389369591321013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19859,594,0.74 [0.61-0.89],0.0020844026056354
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18936,8133,0.92 [0.87-0.97],0.0026404344960751
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20836,124,0.80 [0.52-1.22],0.3030322873725881
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19607,186,0.93 [0.66-1.32],0.6905240679525724
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19935,514,0.77 [0.63-0.95],0.0163526081844482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22450,3185,0.85 [0.78-0.92],0.0001414418470479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19736,315,1.06 [0.81-1.39],0.6893144032224425
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19570,149,0.76 [0.52-1.12],0.1687339997827609
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19536,115,0.51 [0.34-0.78],0.0016052086405448
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22646,104,0.56 [0.35-0.87],0.0102553828066791
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16141,2041,0.81 [0.73-0.90],0.00010673495628
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14907,807,1.07 [0.90-1.27],0.4405067576499183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23307,800,1.10 [0.93-1.30],0.2831510323840334
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14178,78,0.68 [0.40-1.17],0.166726073736309
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14407,307,0.97 [0.73-1.27],0.8038466998130088
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19692,271,0.82 [0.61-1.10],0.181626337876723
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14587,487,1.02 [0.81-1.27],0.8834505921204736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19347,82,0.89 [0.52-1.51],0.656284185693371
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19957,692,0.65 [0.55-0.78],3.687855549316851e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19585,320,0.74 [0.57-0.97],0.0305515471466646
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14556,456,1.05 [0.84-1.32],0.6550999208104937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19494,73,0.80 [0.46-1.40],0.4404597035989318
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19482,61,0.79 [0.43-1.45],0.4489334187369553
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20796,84,0.97 [0.57-1.65],0.9135986274895416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22968,2256,0.87 [0.79-0.96],0.0059280393633439
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22297,1585,0.89 [0.79-1.00],0.0549167107387255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23228,550,0.78 [0.64-0.96],0.017000736497192
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17277,3177,0.87 [0.79-0.94],0.0009853186426274
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14143,43,1.16 [0.55-2.44],0.6955399563343009
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19526,105,0.66 [0.42-1.05],0.0788563164548248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14171,71,0.63 [0.36-1.12],0.1150333748444317
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14236,136,0.66 [0.44-0.99],0.0459742428966096
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20958,246,0.74 [0.54-1.00],0.0473710242059566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21227,515,0.90 [0.73-1.11],0.327598728396469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23381,117,0.66 [0.42-1.01],0.0563836865007292
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21274,2009,0.80 [0.71-0.88],2.536961592488193e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19499,78,1.18 [0.68-2.03],0.561367637544088
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14258,158,1.43 [0.97-2.10],0.0698418372352152
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20064,799,0.73 [0.62-0.87],0.0003615457685906
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16314,2214,0.83 [0.75-0.92],0.000481142129035
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22672,130,0.62 [0.42-0.94],0.0240102831756624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23393,64,2.10 [1.16-3.80],0.0137762763755801
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19500,79,1.02 [0.59-1.75],0.946280905820604
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20791,1370,1.02 [0.89-1.16],0.8031965972328312
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19531,110,1.09 [0.69-1.72],0.7232464504225232
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16203,2103,0.81 [0.73-0.90],8.489097649447287e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20832,120,0.55 [0.36-0.83],0.0049926362658125
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19459,38,0.75 [0.35-1.63],0.475447894456465
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19465,200,0.66 [0.47-0.92],0.01379743792966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20115,694,1.08 [0.90-1.30],0.3814523468537235
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23040,498,0.89 [0.72-1.11],0.2950974811455573
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19932,667,0.89 [0.74-1.07],0.2206728428308094
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23243,544,0.77 [0.63-0.95],0.0131985326662214
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23378,70,0.70 [0.40-1.23],0.2142142122514087
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19590,169,0.72 [0.50-1.03],0.0721998247768592
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18203,903,0.75 [0.64-0.88],0.0003990300164689
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20074,653,1.05 [0.87-1.27],0.6220252845568783
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19704,283,0.99 [0.75-1.32],0.9620494282319956
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14172,72,0.73 [0.42-1.29],0.2783478905022712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17268,3168,0.86 [0.79-0.94],0.0005056306251565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14949,849,0.83 [0.70-0.98],0.0262826044393593
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22924,382,0.79 [0.62-1.02],0.068068418133996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23347,83,0.64 [0.38-1.07],0.0889888011720836
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20702,72,1.09 [0.63-1.90],0.7619449808233187
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14165,65,2.10 [1.16-3.78],0.0136683264418634
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19375,110,1.33 [0.84-2.11],0.2267312529198192
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14658,558,0.74 [0.61-0.91],0.0034483485462856
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19762,341,0.89 [0.69-1.15],0.3665061534924499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19557,292,0.81 [0.61-1.08],0.146788021822585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19534,269,0.67 [0.50-0.89],0.0059905591986334
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16436,68,0.63 [0.36-1.10],0.1040753560386114
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23383,75,0.67 [0.39-1.14],0.1419112731792457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19985,564,0.99 [0.81-1.21],0.9219329358232604
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22634,92,1.34 [0.81-2.21],0.2590004087532163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22098,2677,1.00 [0.91-1.10],0.9794432607527014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19572,151,0.88 [0.59-1.30],0.5112979466233503
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19989,724,0.78 [0.65-0.93],0.0056417687534416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22020,279,0.75 [0.56-1.01],0.0559055433521355
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19525,260,0.76 [0.56-1.02],0.0668187262343248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21299,2034,0.86 [0.77-0.96],0.0057848224805607
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20591,1326,0.91 [0.80-1.04],0.1571292957400514
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19483,62,0.77 [0.42-1.42],0.4080619900757299
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22659,117,0.77 [0.50-1.19],0.2395396058702175
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19587,166,0.93 [0.64-1.35],0.7020659618685232
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19513,92,0.97 [0.59-1.60],0.9042551385578916
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14177,77,0.74 [0.43-1.27],0.2780236108913739
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21875,2280,0.94 [0.85-1.04],0.2385201838474551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9373,26,1.23 [0.48-3.15],0.6704880169917069
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11887,33,1.22 [0.53-2.85],0.6385252151330233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23070,317,1.02 [0.78-1.34],0.8860602877974615
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22859,106,1.32 [0.82-2.11],0.2519083217940271
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21951,2356,0.88 [0.79-0.97],0.0082515996161874
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23170,134,1.67 [1.11-2.52],0.0146324369840169
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23090,410,1.04 [0.82-1.32],0.7395910901501499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,19498,303,0.88 [0.67-1.16],0.3628901431848893
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dialysis,19693,98,1.70 [1.04-2.77],0.0327832997701053
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10315,2174,1.00 [0.90-1.11],0.9571411101084796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11988,134,1.08 [0.71-1.63],0.724844146395021
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,9387,40,0.95 [0.45-2.01],0.887564116978759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9936,589,0.81 [0.67-0.98],0.0336585876470276
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19285,6370,0.92 [0.87-0.98],0.0073391964842917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23134,98,1.24 [0.76-2.01],0.3817666374709673
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydrocele,8261,120,0.98 [0.63-1.53],0.9336626380239428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19665,357,0.80 [0.62-1.02],0.0763529454832946
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9998,1857,1.00 [0.89-1.12],0.9523974773553998
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12053,161,0.74 [0.51-1.07],0.1122886497658274
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8269,128,1.04 [0.68-1.60],0.845214168733808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19284,89,0.61 [0.37-1.00],0.0496803276612463
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10392,1045,0.86 [0.75-1.00],0.052905805556761
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8203,62,1.30 [0.71-2.39],0.3994567990040784
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9386,39,0.47 [0.23-0.94],0.0325198246430891
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23390,89,0.83 [0.50-1.37],0.4628875910854221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23392,86,0.80 [0.48-1.33],0.3899750214173595
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22190,2995,0.91 [0.83-0.99],0.0346872673793396
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20151,956,0.87 [0.75-1.02],0.0884227122066497
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11904,50,1.24 [0.63-2.43],0.5383237481566155
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23316,636,1.04 [0.86-1.25],0.71889562999444
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8297,156,0.95 [0.64-1.40],0.7982403885066276
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8300,159,1.00 [0.68-1.48],0.9820109332360798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8295,154,1.11 [0.75-1.65],0.5982054469773493
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23363,87,1.22 [0.73-2.05],0.4521736666574621
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21574,2379,0.90 [0.82-1.00],0.0454887012264091
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11975,83,0.82 [0.49-1.37],0.4486888935040646
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9416,69,0.68 [0.39-1.19],0.1816610329109734
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9489,142,1.14 [0.76-1.71],0.5172747760583062
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9398,51,0.78 [0.40-1.50],0.4536029444482197
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9450,103,0.68 [0.43-1.07],0.0973057639395886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19729,421,0.88 [0.70-1.12],0.3078961063214349
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22885,205,1.01 [0.72-1.41],0.9613568295198204
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9472,125,0.99 [0.65-1.52],0.9716909643739678
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9372,25,0.51 [0.22-1.20],0.1230974320861174
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9560,213,1.06 [0.76-1.47],0.7274514447354299
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9442,95,0.87 [0.54-1.42],0.5824691141862659
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9558,211,1.21 [0.87-1.67],0.2659179337909648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23083,47,0.97 [0.48-1.96],0.9255738549285526
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8298,157,1.06 [0.72-1.56],0.7714485933864534
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23109,3801,0.91 [0.84-0.98],0.0153848909768822
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19404,96,1.14 [0.69-1.86],0.6145562357983664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19778,183,1.12 [0.79-1.61],0.5196425352020586
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22793,40,0.90 [0.42-1.92],0.7875963786247494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19466,271,0.92 [0.68-1.23],0.5538870736266939
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23157,404,1.05 [0.82-1.33],0.7065239854505272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9383,36,1.94 [0.89-4.22],0.0933657879212736
